Risk of orthostatic hypotension associated with sodium-glucose cotransporter-2 inhibitor treatment: a meta-analysis of randomized controlled trials
The STEP-1 trial that established semaglutide for weight management capped doses at 2.4 mg weekly and produced 14.9% mean body-weight loss over 68 weeks (Wilding et al., 2021)
If you're curious about kind patches glp-1 or kind patches unpuff, definitely stick around for my upcoming posts
A lot of people starting these medications are unfortunately flying blind with respect to what type of nutrition they should be prioritizing. Danone has built several tools to address this gap
Food industry executives are calling up pharma bosses to express their fears and ask for advice about succeeding in the post-Ozempic food era
Instead, they launched the most aggressive product imaginable, forced the FDA into a public response, and that response covers all GLP-1 APIs, including the injectables they were happily selling without scrutiny